Filing Details
- Accession Number:
- 0001477932-24-007969
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-10 16:01:09
- Reporting Period:
- 2024-12-09
- Accepted Time:
- 2024-12-10 16:01:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 93314 | Volitionrx Ltd | VNRX | In Vitro & In Vivo Diagnostic Substances (2835) | 911949078 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1340610 | John Cameron Reynolds | 1489 West Warm Springs Road Suite 110 Henderson NV 89014 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-12-09 | 139,811 | $0.57 | 2,117,404 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,007,718 | Indirect | By Concord International, Inc. |
| Common Stock | 34,076 | Indirect | By Spouse |
Footnotes
- Acquired at the offering price in the registered direct offering of Common Stock by VolitionRx.
- The shares of common stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of common stock held by Concord International, Inc
Billionaire Hedge Funds
